Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Abstract Text:

Miguel A Rubio,Manuel Gargallo,Ana ,Basilio Moreno,Miguel A Rubio,Manuel Gargallo,Ana Isabel Millán,Basilio Moreno,

BACKGROUND: Modification of lifestyle is the main therapeutical approach in the treatment of obesity, but use to fail on long terms of time. Addition of anti-obesity drugs allows keeping the weight loss during years and improving obesity-related comorbidities. METHODS: This review is an actualisation on efficacy, safety and tolerability of the approved drugs on the long-term treatment of obesity (orlistat and sibutramine). New indications and effects of their use far beyond the weight loss are as well commented. Finally, potential benefits of the administration of CB1 antagonist rimonabant on the weight loss and cardiometabolic risk factors are analysed in detail. DISCUSSION: A decade of experience on the use of orlistat and sibutramine has demonstrated their higher efficacy on the weight loss when compared to placebo either on adult or teenage population as well as safety and tolerability on long-term administration. Beneficial effects on the lipid profile, glycosilated haemoglobin on diabetic patients, blood pressure and levels of inflammatory cytokines, contribute to decrease the cardiovascular risk on obese patients. Phase III clinical trials using rimonabant show additional benefits to the expected weight loss, mainly reducing visceral fat and cardiometabolic risk factors. CONCLUSION: Pharmacological treatment of obesity must be considered as a therapeutical tool that has to be used together with long-term lifestyle changes, contributing to the body weight reduction as well as to the improvement of the cardiometabolic risk related to obesity.

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Publishing Authors By Initials

MA Rubio,M Gargallo,A ,B Moreno,MA Rubio,M Gargallo,A Isabel Millán,B Moreno,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Public health nutrition

VOLUME: 10

Page Numbers: 1200-5

Journal Abbreviation:

ISSN: 1368-9800

DAY: 1

MONTH: Oct

YEAR: 2007

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9808463

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.

AFFILIATION: Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, c/ Martín Lagos s/n, 28040 Madrid, Spain. mrubio.hcsc@salud.madrid.org

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Public Health Nutr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant Related Publications

• Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension.
• Analysis of heritable components of primary nocturnal enuresis: relevance of haplotypes instead of genotypes.
• Analysis of porcine peripheral blood mononuclear cells proteome by 2-DE and MS: Analytical and biological variability in the protein expression level and protein identification.
• Characterization and in vitro digestibility of bovine beta-lactoglobulin glycated with galactooligosaccharides.
• Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.
• Effect of inoculation in composting processes: modifications in lignocellulosic fraction.
• Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid.
• Epoxyeicosatrienoic acids induce growth inhibition and calpain/caspase-12 dependent apoptosis in PDGF cultured 3T6 fibroblast.
• Ethics committees: beyond benign neglect.
• Field accumulative behavior of organochlorine pesticides. The role of crabs and sediment characteristics in coastal environments.
• Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
• Nature of perpendicular-to-parallel spin reorientation in a Mn-doped GaAs quantum well: canting or phase separation?
• Polarization beam splitters using polarization diffraction gratings.
• Prevention of allergic diseases.
• Prevention of overweight and obesity: a Spanish approach.
• Purification, crystallization and preliminary X-ray analysis of struthiocalcin 1 from ostrich (Struthio camelus) eggshell.
• Recent advances on cyclins, CDKs and CDK inhibitors.
• Resonant frequencies of Fabry-Perot interferometers with ultrathin mirror spacings.
• Retention and illicit drug use among methadone patients in Israel: a gender comparison.
• Square wave voltcoulometry: a tool for the study of strongly adsorbed redox molecules.
• Tau phosphorylation, aggregation, and cell toxicity.
• The dual-use dilemma.
• The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
• The triumph of autonomy in bioethics and commercialism in American healthcare.
• Thyroid-state influence on protein-expression profile of rat skeletal muscle.
• Towards a global analysis of porcine alveolar macrophages proteins through two-dimensional electrophoresis and mass spectrometry.
• Trends in neurological complications of endocarditis.
• [Comparison study of two glimepiride formulations bioavailability in healthy volunteers of both sexes after a single dose administration]
• [Impact of the new definitions in the prevalence of the metabolic syndrome in an adult population at Bucaramanga, Colombia.]
• [Lupus erythematosus panniculitis presenting as palpebral edema and parotiditis]